|
HS Code |
943569 |
| Chemicalname | 4-Hydroxy-5-Bromo-6-Methylpyrimidine |
| Molecularformula | C5H5BrN2O |
| Molecularweight | 189.01 g/mol |
| Casnumber | 34684-78-9 |
| Appearance | White to off-white solid |
| Meltingpoint | 128-132 °C |
| Solubility | Slightly soluble in water |
| Purity | Typically ≥98% |
| Storageconditions | Store at room temperature, keep dry and tightly closed |
As an accredited 4-Hydroxy-5-Bromo-6-Methylpyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Hydroxy-5-Bromo-6-Methylpyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry keeps reshaping fields we rely on, and nowhere does this show more than in the steady evolution of heterocyclic compounds. Among these, 4-Hydroxy-5-Bromo-6-Methylpyrimidine has become a point of discussion for many working with pyrimidine derivatives in pharmaceuticals and material science. I recall my first encounter with this compound in a research setting: a seemingly modest white to off-white powder that belied its utility. Often, the difference between run-of-the-mill intermediates and a promising product boils down to details in purity and substitution patterns. This compound, drawn from the pyrimidine family, brings its own fingerprint to the table—the 5-bromo and 6-methyl groups are not there just for show. They directly shape how chemists put the molecule to work.
Pyrimidines already play a starring role in medical chemistry, but a look at 4-Hydroxy-5-Bromo-6-Methylpyrimidine reminds us how small changes turn basic scaffolds into powerful tools. Here, the bromo group at position 5 introduces an electron-withdrawing character that often nudges selectivity in coupling and substitution reactions. Methyl at position 6 confers a different set of attributes—a mixture of changed solubility profiles and altered reactivity, which sometimes makes all the difference for downstream synthesis. Hydroxy at position 4 leans into hydrogen bonding networks, influencing how this compound interacts in both organic and water-based systems.
Years spent in the research lab leave you with a particular appreciation for compounds that “just work” under a fairly broad set of conditions. 4-Hydroxy-5-Bromo-6-Methylpyrimidine often performs reliably where other, less functionalized pyrimidines let you down. That’s what keeps it in demand among small-molecule chemists, especially for those designing heterocyclic cores as the foundation for more complex molecules.
Pharmaceutical research never runs out of need for novel building blocks. The bromo-substituted pyrimidines, including this one, frequently act as key intermediates in the assembly of kinase inhibitors, nucleoside analogues, antiviral agents, and other bioactive molecules. The presence of the 5-bromo function allows for Suzuki and Stille couplings—essential moves in modern organic synthesis. I’ve seen several drug discovery projects reach a bottleneck for want of just such a compound—where only a carefully positioned heteroatom or halogen opened the door to new lead structures.
Material science also stakes a claim. Researchers searching for functionalized pyrimidine platforms to anchor optoelectronic materials or as templates in supramolecular chemistry look for modifications like those present here. The hydroxy group can drive advanced hydrogen-bonded networks, and the combination of halogen and methyl tweaks the packing and solubility properties in ways that materials chemists find valuable.
Back in graduate school, the frustration of having unreliable intermediates lingered long after projects finished. Consistency in quality carries real weight. For 4-Hydroxy-5-Bromo-6-Methylpyrimidine, batch-to-batch purity often sits above 98 percent, and this shows in less time wasted troubleshooting side reactions. High-grade material, free of colored impurities or residual solvents, confirms by NMR and LC-MS analysis. I have witnessed firsthand how a reliable supplier—who understands your limits on nitro or heavy metal contamination—makes or breaks months of bench work.
Moisture content also draws attention, especially in reactions sensitive to water. Product packed and sealed with proper desiccants travels safely, resisting clumping and chemical degradation, giving peace of mind from lab to pilot plant. I learned quickly that you sacrifice yield, not to mention patience, if the compound arrives slightly off-specification. This is where trustworthy distribution and clear, accessible analysis data shine.
Some might look at a catalog and see just a series of small tweaks: a bromine swapped for chlorine, a hydroxy traded for an amino. The truth is, these little changes steer the whole outcome of a synthesis. For example, 5-bromopyrimidines typically take to palladium catalysis more kindly than 5-chloro versions, which may resist coupling or create side products under the same conditions. This can turn a standard cross-coupling from a two-day struggle into a clean morning’s reaction, something I’ve personally celebrated on more than one late night at the fume hood.
The hydroxy group, too, fills dual roles—on one side, a reliable handle for O-alkylation or acylation, and on the other, a hydrogen bond participant that often improves crystallinity. Changing it for an amino or nothing at all ripples down to physical properties, including melting points and solubility, which have implications for purification and downstream workup. Methyl at position 6 shifts the molecule’s overall polarity and can subtly change how readily other reagents approach the ring for substitution or other transformations.
Based on hands-on experience, this compound lands in the sweet spot of reactivity and selectivity. Researchers hunting for a bromo-pyrimidine that won’t overreact or create polymers on first contact with base or catalyst routes often circle back here. Among similar molecules, it offers a balance of halogen reactivity, hydrogen bonding, and solubility that fits a wide variety of reaction set-ups. This versatility has kept it relevant across both pharma and specialty chemical development, long after fads have come and gone.
Product stability plays a different game. Some pyrimidines prove sensitive to oxygen or light, slowly transforming before they reach a bench or reactor. This one, in my experience, holds up well under typical storage—provided it’s kept dry and away from strong acids or bases, it stays ready for months. Ease of weighing, dissolving, and filtering matters in high-throughput experiments as much as it does in kilo-scale production.
The journey from bench chemical to market-ready pharmaceutical or technology rarely goes smoothly. Roadblocks often pop up in late-stage synthesis or during upscaling. 4-Hydroxy-5-Bromo-6-Methylpyrimidine has popped up in case studies where access to its unique substitution pattern unlocked routes to previously stubborn targets. For instance, one story from a former colleague involved a kinase inhibitor project stalled by poor yield on a key coupling step. Swapping in this compound led to a leap in linear yield, unlocking bioassay work that otherwise would have been impossible at a practical scale.
In my own work with nucleoside analogues, small differences at the pyrimidine core produced better pharmacokinetic profiles, thanks to modified hydrogen bonding and metabolic stability. A reliable source of the right intermediate made the step from milligrams to grams a reality. Here, the lessons learned did not rest on the compound’s structure alone—handling, measurement, and purity mattered just as much.
Rising demand for specialized heterocyclic intermediates means chemists and buyers face cost pressures and sourcing headaches. This isn’t a molecule that can be whipped up in large-scale batches by just any supplier. Subtle adjustments in bromination or methylation conditions can skew impurity profiles or drop yields unexpectedly. I’ve seen labs forced to troubleshoot variabilities that creep in as they shift from pilot quantities to true production volumes.
Global movement of chemical feedstocks further complicate the picture. Shifting regulatory outlooks on halogenated intermediates also raise eyebrows. Certifications like REACH or compliance with good manufacturing practices put extra scrutiny on sources of 4-Hydroxy-5-Bromo-6-Methylpyrimidine, especially where final use touches human health. Not every manufacturer can keep pace with this level of oversight. Over the years, I’ve found that questions about documentation, traceability, and parent raw materials are as important as any certificate of analysis. There’s peace of mind in knowing that your route won’t hit an unexpected bump from a regulatory flag or supply gap.
If you depend on reliable supply for sensitive downstream tasks, my advice boils down to a few proven strategies. First, build a long-term relationship with suppliers who demonstrate transparent batch records, who share not just purity numbers but details on synthetic methods and impurity spectra. Suppliers who communicate openly save you headaches compared to those who only offer generic assurances.
Batch reservation—committing to a larger lot held in secure storage—can help moderate price swings and sudden shortages. It also sidesteps shifts in quality that may plague smaller, off-the-shelf volumes. If you’re running complicated syntheses, sample multiple lots for pilot reactions. Even reputable vendors sometimes produce subtle differences that show up only under real-world conditions. Early on, plan for these trial runs, even if it means a slight delay before full-scale production.
Pursue documentation beyond a basic certificate of analysis. Analytical chromatograms, NMR, and heavy metal content—in my experience, these often prove invaluable down the road. Regulatory-compliant suppliers increasingly share this data proactively, and partnerships that start with this transparency generally last.
On the laboratory side, invest in standardizing how you handle, store, and weigh out the product. Avoid unnecessary moisture by storing it in a dry box, and use dedicated spoons or spatulas to reduce cross-contamination. For scale-up or repeat projects, confirm storage stability over the expected time frame. These small investments up front have prevented project-halting problems for me more times than I can count.
Every time a robust intermediate like 4-Hydroxy-5-Bromo-6-Methylpyrimidine becomes more widely accessible, it nudges the whole field forward. Lowering the barrier for entry-level synthetic chemists, or giving startups access to quality materials without the risk of unexpected impurities, translates to a more level playing field in discovery and innovation. Universities, where budgets run tight and purity can’t be taken for granted, particularly benefit from proven sources and up-to-date analytical data.
In collaborative projects, clear and reliable materials sourcing speeds the cycle: less time spent on QC workarounds, more time devoted to discovery or testing. I’ve noticed that well-supported product portfolios often foster cross-disciplinary work, enabling biotech and material science labs to tackle questions they’d otherwise set aside.
The push toward greener chemistry and sustainable synthesis puts established compounds like this under fresh scrutiny. Researchers increasingly emphasize low-waste, energy-efficient protocols. Advances in catalytic techniques, including flow chemistry and alternate halogen sources, may someday reshape how 4-Hydroxy-5-Bromo-6-Methylpyrimidine comes to market. Just as tweaks to starting materials can lead to whole new classes of medicines, greener and more efficient pathways will change the landscape for this and related products.
As a chemist, I keep my eye on new publications and patents around pyrimidine chemistry, watching for both synthetic breakthroughs and changes on the regulatory horizon. Continuous improvement—finding ways to minimize hazardous reagents, lower energy costs, and provide reproducible, high-quality intermediates—remains a shared goal. The industry overall benefits when suppliers embrace these changes, and the research community gains more freedom to innovate.
Reflecting on years at the bench reinforced a simple truth: no matter how clever the idea, scientific progress leans hard on the reliability of basic chemistries. 4-Hydroxy-5-Bromo-6-Methylpyrimidine sits at the crossroads of tradition and innovation. Its careful balance of function, purity, and stability paves the way for advances that ripple well beyond the flask, touching fields from drug discovery to materials design.
This molecule, with its distinctive substitution pattern, continues to earn its place—not just by what shows up on paper, but by smoothing the rough edges of daily lab work, powering new discoveries, and by giving scientists room to push boundaries with confidence in their fundamental tools.